Aplastic anemia: Focus on treatment with anti-thymocyte globulin Journal Article

  


Authors: Diaz, W.; Salamone, F. R.; Muller, R. J.
Article Title: Aplastic anemia: Focus on treatment with anti-thymocyte globulin
Abstract: Severe aplastic anemia 8SAA) is a life-threatening disease. In most cases, the etiology cannot be determined at the time of diagnosis. The exact pathogenesis of the disorder continues to be investigated, although current evidence suggests an autoimmune process. Bone marrow transplantation (BMT) continues to be the primary treatment for patients who meet the criteria. For those patients who are not candidates for bone marrow transplantation, ATG therapy has become the alternate choice.
Keywords: cytology; infection; paracetamol; methylprednisolone; corticosteroid; bone marrow transplantation; erythrocyte transfusion; anaphylaxis; granulocytopenia; intravenous drug administration; thymocyte antibody; aplastic anemia; thrombocyte transfusion; anabolic agent; human
Journal Title: Hospital Pharmacy
Volume: 24
Issue: 9
ISSN: 0018-5787
Publisher: Sage Publications  
Date Published: 1989-10-01
Start Page: 737
End Page: 741, 754
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024435859&partnerID=40&md5=9d184514f0c98ee3f3c909201b24b5ac
Notes: Article -- Export Date: 14 April 2020 -- Source: Scopus